title: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition.
abstract: We examined steady-state levels of mRNA encoding type IV collagen, B1 chain of laminin, and the basement membrane heparan sulfate proteoglycan in the kidney cortex of a mouse model (KKAy) of non-insulin-dependent diabetes. mRNAs encoding laminin B1 and the proteoglycan were unchanged in kidneys taken from diabetic mice with demonstrable basement membrane thickening. mRNA levels for type IV collagen, in contrast, were significantly elevated (2-fold) in diabetic mice concurrent with but not preceding morphologically thickened basement membranes. There was a negative correlation between a ratio of proteoglycan/type IV collagen and levels of albuminuria in the diabetic mice. No correlation was noted with laminin. We also examined the effects of inhibiting the synthesis of thromboxane, a potent vasoconstrictor, on the steady-state levels of type IV collagen in the diabetic mice. Inhibition of thromboxane stopped the progression of albuminuria and prevented an increase in type IV collagen mRNA levels. We conclude that basement membrane thickening in diabetes, a hallmark of diabetic nephropathy, is partly a consequence of an unbalanced increase in the production of type IV collagen. The relative decrease in proteoglycan production may contribute to chronic albuminuria.
authors.affiliation: Upjohn Company, Kalamazoo, Michigan 49001.
authors.forename: S
authors.initials: S
authors.lastname: Ledbetter
authors.forename: E J
authors.initials: EJ
authors.lastname: Copeland
authors.forename: D
authors.initials: D
authors.lastname: Noonan
authors.forename: G
authors.initials: G
authors.lastname: Vogeli
authors.forename: J R
authors.initials: JR
authors.lastname: Hassell
mesh_terms: D000818:Animals; D001485:Basement Membrane / Q000737:chemistry / Q000378:metabolism; D003094:Collagen / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000235:genetics / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000378:metabolism*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006497:Heparan Sulfate / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D007668:Kidney / Q000737:chemistry / Q000378:metabolism*; D007797:Laminin / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D008297:Male; D051379:Mice; D009693:Nucleic Acid Hybridization; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D003094:Collagen; D006497:Heparan Sulfate; D007797:Laminin; D012333:RNA, Messenger; D013930:Thromboxane-A Synthase; D014662:Vasoconstrictor Agents